Stakeholder Call - Guillain-Barré Syndrome (GBS), COVID-19 Vaccine Updates - 7/15/21
Acting FDA Commissioner Janet Woodcock, M.D. and the Director of FDA's Center for Biologics Evaluation and Research, Peter Marks, M.D., Ph.D., discuss preliminary reports of Guillain-Barré Syndrome (GBS) following Janssen #COVID19 vaccination.
Видео Stakeholder Call - Guillain-Barré Syndrome (GBS), COVID-19 Vaccine Updates - 7/15/21 канала U.S. Food and Drug Administration
Видео Stakeholder Call - Guillain-Barré Syndrome (GBS), COVID-19 Vaccine Updates - 7/15/21 канала U.S. Food and Drug Administration
Показать
Комментарии отсутствуют
Информация о видео
31 июля 2021 г. 2:48:24
00:43:22
Другие видео канала
Vaccines and Related Biological Products Advisory Committee – 9/17/2021
Stakeholder Call: Pfizer-BioNTech COVID-19 Vaccine Booster Dose - 9/24/21
COVID-19 Vaccines & Women
Stakeholder Call: COVID-19 Vaccine for Children 5-11 Years Old – 11/01/2021
Media Call: Pfizer-BioNTech COVID-19 Vaccine Actions – 1/3/2022
ADMS Establishment Databook Walk Through
Natural History Studies for Rare Diseases
FDA and CDC Virtual Press Conference: Johnson & Johnson COVID-19 Vaccine - 4/23/2021
Vaccines and Related Biological Products Advisory Committee, Day 2 – 10/15/2021
ADMS Supply Chain Databook Walk Through
Joint Media Call: FDA & CDC to Discuss Janssen COVID-19 Vaccine - 4/13/2021
Stakeholder Call: COVID-19 Vaccine Update - 4/27/2021
“Just a Minute!” with Dr. Peter Marks – Why Should I Get a COVID-19 Booster?
¿Estás comiendo demasiada sal? 4 maneras de reducir la sal gradualmente ...
FDA Media Call: Oral Antiviral Treatments for COVID-19
Stakeholder Call: FDA Takes Steps to Improve the Quality, Safety and Efficacy of Sunscreen – 9/27/21
Biosimilars: Manufacturing and Inherent Variation
Cellular, Tissue, and Gene Therapies Advisory Committee (CTGTAC) Meeting - Day 2
Increasing Diversity in Lupus Clinical Trials
2021 REdI Conference Keynote Address by Janet Woodcock, MD